Skip to content

Clinical trials

Phase 3 Muscular Atrophy, Spinal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Atrophy, Spinal Phase: Phase 3 Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20142
20151
20171
20181
20191
20201
20212
20225
20232
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting4
Active, not recruiting4
Withdrawn1
Terminated1
Unknown status1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen9
Novartis Pharmaceuticals4
Novartis Gene Therapies3
Scholar Rock, Inc.2
All India Institute of Medical Sciences1
Biohaven Pharmaceuticals, Inc.1
GeneCradle Inc1
Lantu Biopharma1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Atrophy, Spinal23
Muscular Atrophy6
Muscular Diseases4
Spinal Muscular Atrophies of Childhood4
Bulbo-Spinal Atrophy, X-Linked3
Neuromuscular Diseases3
Atrophy2
Neuromuscular Manifestations2

Trials

Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.